OHSU

Richard T. Maziarz, M.D.

Head Shot of Richard Maziarz
Email: 
click here
Office: 
503 494-5058

Background

Dr. Maziarz’ research focus is cellular immune system recovery after bone marrow transplantation, tumor vaccine development, stem cells for tissue repair and infections in the immune-compromised host.


Summary of Current Research

Additional Special Interests

Graft vs. host disease, immunotherapy and regeneration medicine.


Selected Publications

"Adult adherent stromal cells in the management of graft-versus-host disease," Expert Opinion on Biological Therapy (Vol: 14, Issue: 2, Page 231-246) - 2014

"Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.," Journal of clinical oncology : official journal of the American Society of Clinical Oncology (Vol: 32, Issue: 4, Page 273-281) - 2014

"Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?," Biology of Blood and Marrow Transplantation (Vol: 20, Issue: 3, Page 421-424) - 2014

"Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma," Leukemia and Lymphoma (Vol: 55, Issue: 3, Page 583-587) - 2014

"Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study," Clinical Lymphoma, Myeloma and Leukemia - 2014

 

OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


Contact

  Email Richard Maziarz

503 494-5058

Memberships & Associations

American Society of Hematology
American Society of Bone Marrow Transplant
International Society of Cellular Therapy
International Society of Experimental Hematology
Southwest Oncology Group
Puget Sound Oncology Consortium